Financials

Discussions Technicals Seasonals

6483 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

6483 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company